- FDA Rules for Cigarettes Are a Victory for Public Health, for Science (and for the Earth’s Climate?)
- Legislation Introduced to Codify Stem Cell Rules
- Commissioner Enhances FDA’s Commitment to Personalized Medicine
- Perfecting Policy on Stem Cells
- NIH and FDA Aim to Retool Regulatory Science
- DOE Leads Federal Funding for a Regional Innovation Cluster
- Certainty on the Science of Climate Change
- They’re Not Perfect Cells, But They’re Model Cells
- Genomic Medicine on the March
- President’s Budget Aims to Recharge Regional Innovation
- Event: The Science of Climate Change
- Progress in Bioethics
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
House Moves to Regulate Unregulated Drug Delivery Systems
flick.com/SuperFantastic
An estimated 20.8 percent of all adults (45.3 million people) smoke cigarettes in the United States.
With the support of cigarette manufacturer Phillip Morris USA, the House voted Wednesday to approve legislation that would give the Food and Drug Administration the power to regulate tobacco. According to The New York Times, the bill would give the FDA the authority to stipulate nicotine levels allowed in cigarettes sold to consumers, and the agency could mandate a nonaddictive threshold for the chemical.
Writing about the legislation in March, Michael Stebbins noted that without the ability to ban nicotine outright, the FDA would not have sufficient power:
A superficial glance at the bill reveals that it fails the logic test by requiring an agency charged with protecting the health of Americans with regulating a deadly product without the authority to ban it outright. But the alternative, of leaving Big Tobacco to freely manipulate their product to keep me and the rest of my stinky-fingered brethren addicted, is unacceptable.
Stebbins notes as well that “In the United States, cigarette smoking is responsible for about one in five deaths annually, or about 438,000 deaths per year; on average, these people die 13 years younger than non-smokers.” Moreover, “Annually, cigarette smoking costs more than $167 billion, based on lost productivity ($92 billion) and health care expenditures ($75.5 billion).” “Cigarettes,” he points out, “are unregulated drug delivery systems.”
With the ability to regulate tobacco, FDA could better protect the health of Americans and prevent young people from becoming early smokers. But if the lessons from past battles with the tobacco industry are any lesson, there may be fights on the horizon to defend the science that will put teeth in FDA’s authority. As David Michaels, author of Doubt Is Their Product, noted in an interview earlier this year, there are many industry tricks of the trade that “turn positive studies into negative ones or take one positive study and do a literature review which buries the positive study in what is essentially a whole mass of garbage so it looks like there is nothing there.” Let’s hope that legal arguments over the precise levels levels of nicotine allowed in cigarettes do not obscure the fact that the product kills.
Comments on this article


